Extracellular matrix constitutes a non-cellular entity within all tissues and organs that provides biochemical and mechanical support to surrounding cells. It plays a crucial role in cell adhesion, migration, proliferation, and differentiation. Advancements in tissue engineering techniques and growth factors are facilitating regenerative medicine approaches for tissue repair using engineered extracellular matrices.
The global Extracellular Matrix Market is estimated to be valued at US$ 7.2 billion in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Advancements in tissue engineering techniques are one of the key trends driving growth of the extracellular matrix market. Rapid developments are being made in designing synthetic and natural scaffolds that can closely mimic native extracellular matrix. These include new hydrogel formulations and decellularization approaches to derive extracellular matrices from animal and human tissues. Continuous research focusing on optimizing scaffold properties such as mechanical strength, degradation rate, and interactions with cells through bioactive signals and adhesion proteins, is allowing development of improved tissue constructs for regenerating various tissues. Growing applications of these engineered extracellular matrices in regenerating skin, bone, cartilage, blood vessels and other tissues is expected to boost demand over the forecast period.
Segment Analysis
The global extracellular matrix market is segmented by type, application, and end user. Based on type, the market is segmented into hydrogels, hyaluronic acid, collagen matrices, and specialized matrices. The collagen matrices segment held the largest market share in 2022 owing to its high use in wound healing, drug delivery, and soft tissue reconstruction procedures.
Key Takeaways
The Global Extracellular Matrix Market Size is expected to witness high growth during the forecast period from 2024 to 2031. The global Extracellular Matrix Market is estimated to be valued at US$ 7.2 billion in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2031.
Regional analysis: North America currently holds the largest share of the extracellular matrix market and is expected to continue its dominance during the forecast period. This is attributed to advanced healthcare infrastructure and increasing R&D investments for developing novel ECM products. The Asia Pacific region is expected to witness the highest growth rate owing to rising medical tourism, growing geriatric population, and increasing focus of key players in expanding their presence in emerging Asian countries.
Key players: Key players operating in the extracellular matrix market are Axogen, Integra Lifesciences, Collagen Matrix, Inc., Stryker Corporation, Medtronic, and Organogenesis, Inc. Axogen holds a major market share due to its strong product portfolio in peripheral nerve regeneration and surgical solutions. Integra Lifesciences is focused on expanding product indications through ongoing R&D activities and new product launches.
Get more insights on this topic:
https://www.dailyprbulletin.com/extracellular-matrix-market-insights/
Explore more trending article:
https://www.dailyprbulletin.com/packaging-design-services-market-insights/
Comments
0 comment